Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 5/20 | 0.56 |
| ▸ | CHKA | P35790 | 1/20 | 0.47 |
| ▸ | PDE5A | O76074 | 2/20 | 0.45 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 3/20 | 0.39 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.39 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.39 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5082461 | 0.78 | CSF1R (0.51) | CSF1RCHKAKMT2AEGFRCSNK2A2 | |
| SCHEMBL23601070 | 0.76 | CSF1R (0.68) | CSF1RCHKAPDE5AEGFR | |
| SCHEMBL432877 | 0.76 | MEN1 (0.57) | CSF1RPDE5AABCG2MEN1KMT2A | |
| SCHEMBL5081902 | 0.75 | HTR3A (0.45) | PDE5A | |
| SCHEMBL3123760 | 0.72 | CSF1R (1.00) | CSF1RCHKAEGFR | |
| SCHEMBL432071 | 0.72 | PDE5A (0.62) | PDE5AMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL8165127 | 0.71 | CSF1R (0.97) | CSF1RCHKAEGFR | |
| SCHEMBL30961034 | 0.71 | CSF1R (0.60) | CSF1RCHKAEGFR | |
| SCHEMBL23601802 | 0.71 | CSF1R (0.60) | CSF1RCHKAEGFR | |
| SCHEMBL23577274 | 0.70 | EGFR (0.59) | CSF1RCHKAPDE5AEGFRCSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009013286-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2009-01-29 | — | — | WO | claimed |
| EP-1890699-A1 | INDACTEROL DERIVATIVES AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF AIRWAY DISEASES | Novartis AG (CH) | 2008-02-27 | — | — | EP | claimed |
| WO-2006128675-A1 | INDACTEROL DERIVATIVES AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF AIRWAY DISEASES | NOVARTIS AG (CH) | 2006-12-07 | — | — | WO | claimed |
| EP-2755708-A2 | INHALER | Astrazeneca AB (SE) | 2014-07-23 | — | — | EP | disclosed |
| EP-2755707-A1 | INHALER | Astrazeneca AB (SE) | 2014-07-23 | — | — | EP | disclosed |
| EP-2595683-A2 | INHALER | AstraZeneca AB (SE) | 2013-05-29 | — | — | EP | disclosed |
| EP-2595684-A1 | INHALER | AstraZeneca AB (SE) | 2013-05-29 | — | — | EP | disclosed |
| WO-2013038170-A2 | INHALER | ASTRAZENECA AB (SE) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013038169-A1 | INHALER | ASTRAZENECA AB (SE) | 2013-03-21 | — | — | WO | disclosed |
| EP-2534054-A1 | PROCESS FOR PROVIDING A FILLED CANISTER FOR AN INHALER | AstraZeneca UK Limited (GB) | 2012-12-19 | — | — | EP | disclosed |
| EP-2448623-A1 | DISPENSER AND METHOD FOR ENTRAINING POWDER IN AN AIRFLOW | AstraZeneca AB (SE) | 2012-05-09 | — | — | EP | disclosed |
| WO-2010042036-A1 | INHALER WITH AUDIBLE INDICATOR MEANS | ASTRAZENECA AB (SE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010042035-A1 | INHALER WITH INDEXING LINKED TO MOVEMENT OF COVER | ASTRAZENECA AB (SE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010042034-A1 | A BREATH ACTIVATED INHALER | ASTRAZENECA AB (SE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010042033-A1 | INHALATION DEVICE AND METHOD OF DISPENSING MEDICAMENT | ASTRAZENECA AB (SE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2009154562-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A 4-HYDROXY-2-OXO-2, 3- DIHYDRO-1, 3-BENZOTHIAZOL-7-YL COMPOUND FOR MODULATION OF BETA2-ADRENORECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2009-12-23 | — | — | WO | disclosed |
| WO-2009037503-A2 | NEW COMBINATION - 012 FOR THE TREATMENT OF RESPIRATORY DISEASES | ASTRAZENECA AB (SE) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009013286-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2009-01-29 | — | — | WO | disclosed |
| EP-1890699-A1 | INDACTEROL DERIVATIVES AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF AIRWAY DISEASES | Novartis AG (CH) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006128675-A1 | INDACTEROL DERIVATIVES AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF AIRWAY DISEASES | NOVARTIS AG (CH) | 2006-12-07 | — | — | WO | disclosed |